Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease

Convalescent plasma (CP) therapy in COVID-19 disease may improve clinical outcome in severe disease. This pilot study was undertaken to inform feasibility and safety of further definitive studies. This was a prospective, interventional and randomized open label pilot trial in patients with severe CO...

Descripción completa

Detalles Bibliográficos
Autores principales: AlQahtani, Manaf, Abdulrahman, Abdulkarim, Almadani, Abdulrahman, Alali, Salman Yousif, Al Zamrooni, Alaa Mahmood, Hejab, Amal Hamza, Conroy, Ronán M., Wasif, Pearl, Otoom, Sameer, Atkin, Stephen L., Abduljalil, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113529/
https://www.ncbi.nlm.nih.gov/pubmed/33976287
http://dx.doi.org/10.1038/s41598-021-89444-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113529/
https://www.ncbi.nlm.nih.gov/pubmed/33976287
http://dx.doi.org/10.1038/s41598-021-89444-5

Ejemplares similares